NVAX trending up pullback for entry LONG

NVAX hit a swing low to open the week and has celebrated federal actions

related to vaccine development with the current uptrend. Having a bit of a

pullback, I see room for an entry. Other vaccine stocks have ad a good week

notably MRNA. This further supports an entry here as buyers from earlier

in the week take their profits. NVAX has been heavily shorted. It is a short

squeeze candidate. An entry here makes sense to me.

Trade ist aktiv:

NVAX got a nice 25% pop on earnings. Call options up 140%. Closing 2/3 of them- watching for a drop / correction.

Trade ist aktiv:

NVAX holding steady despite down-trending market showing relative strength.